PDL BioPharma, Inc. Proceeds from Hedge, Financing Activities
PDL BioPharma, Inc. reported Proceeds from Hedge, Financing Activities of $10.87 million for the 9-month period ending 2011-09-30, per its 10-Q filed 2012-11-05.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromHedgeFinancingActivities · last filed 2012-11-05
- 2011-09-30: Proceeds from Hedge, Financing Activities 9 month $10.87M.
| Period end | Proceeds from Hedge, Financing Activities 9 month |
|---|---|
| 2011-09-30 | $10.87M 10-Q · filed 2012-11-05 |